Brief: Shanghai Junshi Biosciences To Will Fosun Wanbang Right To Develop, Others, Roconkibart ("Js005") In Greater China Region
01/07/2026 12:59
BRIEF-Shanghai Junshi Biosciences To Will Fosun Wanbang Right To Develop, Others, Roconkibart ("Js005") In Greater China Region July 1 (Reuters) - Shanghai Junshi Biosciences Co Ltd 688180.SS:
WILL GRANT FOSUN WANBANG RIGHT TO DEVELOP, OTHERS, ROCONKIBART ("JS005") IN GREATER CHINA REGION
Further company coverage: 688180.SS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Junshi Biosciences
See all newsBrief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Receives Supplemental Drug Approval From NMPA
Brief: Shanghai Junshi Biosciences's Shareholder Plans To Cut Stake
Brief: Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For Toripalimab